Starbucks Stops Covering Weight-Loss Drugs Under Employee Plans
Starbucks has announced it will no longer cover GLP-1 medications for weight loss under its employee health plans, citing rising costs. The move reflects a broader trend among US employers recalibrating benefits as spending on GLP-1 drugs surges.